CECC announces supply agreement with Moderna for additional 36 million doses of Moderna’s COVID-19 vaccine

On July 22, the Central Epidemic Command Center (CECC) announced that it has signed a supply agreement with U.S. pharmaceutical company Moderna Inc. to purchase a total of 35 million doses of Moderna's COVID-19 vaccine in the next two years and that under the supply agreement, Moderna will supply doses of its prime series and updated variant booster vaccine candidate in batches in 2022 and 2023, in an effort to respond to the threats posed by SARS-CoV-2 variants and offer vaccines to more groups of people. The CECC also purchased an additional 1 million doses of the Moderna vaccine, which will be delivered in the fourth quarter of 2021, to meet the demand for vaccinations of the Taiwanese public.

發佈日期 2021/7/22